1. Understanding COPD Slideshow
2. COPD (Chronic Obstructive Pulmonary Disease) Quiz
3. Energy Foods for COPD Slideshow Pictures

Medical Author:

George Schiffman, MD, FCCP

George Schiffman, MD, FCCP

Dr. Schiffman received his B.S. degree with High Honors in biology from Hobart College in 1976. He then moved to Chicago where he studied biochemistry at the University of Illinois, Chicago Circle. He attended Rush Medical College where he received his M.D. degree in 1982 and was elected to the Alpha Omega Alpha Medical Honor Society. He completed his Internal Medicine internship and residency at the University of California, Irvine.

View Full Profile

Medical Editor:

Charles Patrick Davis, MD, PhD

Charles Patrick Davis, MD, PhD

Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.

View Full Profile

Author: George Schiffman, MD, FCCP

Editor: Charles P. Davis, MD, PhD

REFERENCES:

Albert, et al. Azithromycin for Prevention of Exacerbations of COPD. NEJM 2011;365:689-698.

Badrul A. Chowdhury, M.D. et al. The Risks and Benefits of Indacaterol - The FDA's Review. N Engl J Med 2011; 365:2247-2249. December 15, 2011.

Cahill K, Stead LF, Lancaster T (2012). "Nicotine receptor partial agonists for smoking cessation". Cochrane Database Syst Rev 4: CD006103.

FDA.gov. FDA Approves Breo Ellipta to treat chronic obstructive pulmonary disease.

FDA.gov. FDA approves a new drug to treat chronic obstructive pulmonary disease.

Global Initiative for Chronic Obstructive Lung Disease. Updated 2010.

Hopkinson, N, Bronchoscopic lung volume reduction: indications, effects and propects. Current Opinion in Pulmonary Medicine March 2007; vol 13; issue 2 ;125-130.

Lahzami, S., Aubert, JD; Lung trasnplantation for COPD-evidence-based? Swiss Med Wkly. 2009; Jan 10;139(1-2);4-8.

Previous contributing authors and editors: Author: Sat Sharma, MD, FRCPC, FCCP, Program Director, Associate Professor, Department of Internal Medicine, Divisions of Pulmonary and Critical Care Medicine, University of Manitoba; Site Coordinator of Respiratory Medicine, St Boniface General Hospital. Editors: Ryland P Byrd Jr, MD, Chief of Pulmonary Medicine, Medical Director of Respiratory Therapy, Quillen VA Medical Center; Professor, Department of Internal Medicine, Division of Pulmonary Diseases and Critical Care Medicine, James H Quillen College of Medicine, East Tennessee State University; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Zab Mosenifar, MD, Director, Division of Pulmonary and Critical Care Medicine, Executive Vice Chair, Department of Medicine, Cedars Sinai Medical Center, Professor of Medicine, University of California at Los Angeles School of Medicine.

Must Read Articles Related to Chronic Obstructive Pulmonary Disease (COPD)

Asthma Asthma is a disease that affects the breathing passages of the lungs (bronchioles). Asthma may be caused by genes and environmental factors. Asthma causes wheez...learn more >>

Bronchitis Bronchitis is acute or chronic inflammation of the air passages in the lungs. There are several viruses and bacteria that cause bronchitis. Exposure to pollutan...learn more >>

Cigarette Smoking Cigarette smoking remains the leading cause of death and illness among Americans. Effects of smoking can cause cancers, emphysema, bronchitis, COPD, chronic cou...learn more >>

See the Entire Chronic Obstructive Pulmonary Disease (COPD) Topic Guide »